Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             53 results found
no title author magazine year volume issue page(s) type
1 Adverse effects might predict response in breast cancer Sharma, Sharan Prakash
 2013
 14 7 p. e258-
1 p.
 article
2 Asbestos is not just asbestos: an unrecognised health hazard Baumann, Francine
 2013
 14 7 p. 576-578
3 p.
 article
3 A selective ALK inhibitor in ALK-rearranged patients Yang, James Chih-Hsin
 2013
 14 7 p. 564-565
2 p.
 article
4 Aurora kinase B inhibitor benefits elderly patients with AML Sharma, Sharan Prakash
 2013
 14 7 p. e255-
1 p.
 article
5 Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer Fayda, Merdan
 2013
 14 7 p. e250-
1 p.
 article
6 Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer Boyages, John
 2013
 14 7 p. e250-e251
nvt p.
 article
7 Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer – Authors' reply Galimberti, Viviana
 2013
 14 7 p. e251-e252
nvt p.
 article
8 Bevacizumab is linked to cases of necrotising fasciitis Wong, Jennifer
 2013
 14 7 p. e259-
1 p.
 article
9 Cancer apps Burki, Talha Khan
 2013
 14 7 p. 580-581
2 p.
 article
10 Cancer stem cells—therapeutic targeting or therapy? Filipovic, Aleksandra
 2013
 14 7 p. 579-580
2 p.
 article
11 Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial Crosby, Thomas
 2013
 14 7 p. 627-637
11 p.
 article
12 CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study Seto, Takashi
 2013
 14 7 p. 590-598
9 p.
 article
13 Contralateral risk-reducing mastectomy in sporadic breast cancer Murphy, John A
 2013
 14 7 p. e262-e269
nvt p.
 article
14 Correction to Lancet Oncol 2013; 14: 557 2013
 14 7 p. e254-
1 p.
 article
15 Correction to Lancet Oncol 2013; 14: 297 2013
 14 7 p. e254-
1 p.
 article
16 Correction to Lancet Oncol 2013; 14: 481 2013
 14 7 p. e254-
1 p.
 article
17 Cosmetic implants could delay breast cancer diagnosis Burki, Talha Khan
 2013
 14 7 p. e260-
1 p.
 article
18 Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study Morita, Tatsuya
 2013
 14 7 p. 638-646
9 p.
 article
19 Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial Amadori, Dino
 2013
 14 7 p. 663-670
8 p.
 article
20 Evolution of prostate cancer gene mutations Burki, Talha Khan
 2013
 14 7 p. e257-
1 p.
 article
21 Extending the case for oestradiol in androgen-sensitive prostate cancer Wassersug, Richard J
 2013
 14 7 p. e252-e253
nvt p.
 article
22 Extending the case for oestradiol in androgen-sensitive prostate cancer – Authors' reply Langley, Ruth
 2013
 14 7 p. e253-
1 p.
 article
23 Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial Jin, Jie
 2013
 14 7 p. 599-608
10 p.
 article
24 Image-guided brachytherapy effective for cervical cancer Tanday, Sanjay
 2013
 14 7 p. e256-
1 p.
 article
25 Imatinib is exorbitantly priced despite protests Wong, Jennifer
 2013
 14 7 p. e258-
1 p.
 article
26 Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study Ciatto, Stefano
 2013
 14 7 p. 583-589
7 p.
 article
27 Integration of general oncology and palliative care Kaasa, Stein
 2013
 14 7 p. 571-572
2 p.
 article
28 Is there a standard induction regimen for patients with AML? Ravandi, Farhad
 2013
 14 7 p. 565-566
2 p.
 article
29 It's time to quit The Editors,
 2013
 14 7 p. 578-
1 p.
 article
30 Molecular mutations in atypical chronic leukaemia Burki, Talha Khan
 2013
 14 7 p. e261-
1 p.
 article
31 New combination treatment for anaplastic thyroid cancer Sharma, Sharan Prakash
 2013
 14 7 p. e256-
1 p.
 article
32 No fall in mammogram rates after USPSTF recommendations Marshall, Hilary
 2013
 14 7 p. e255-
1 p.
 article
33 Pale Girl Speaks Penny, Helen
 2013
 14 7 p. 582-
1 p.
 article
34 Pancreaticoduodenectomy: time to change our approach? Wolfgang, Christopher L
 2013
 14 7 p. 573-575
3 p.
 article
35 Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial Topal, Baki
 2013
 14 7 p. 655-662
8 p.
 article
36 Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial Arits, Aimée HMM
 2013
 14 7 p. 647-654
8 p.
 article
37 Platelet prophylaxis for haematological cancers Baker, Holly
 2013
 14 7 p. e261-
1 p.
 article
38 Potential drug targets in acute myeloid leukaemia Benmaamar, Ramla
 2013
 14 7 p. e259-
1 p.
 article
39 Prognosis of breast cancer during pregnancy Baker, Holly
 2013
 14 7 p. e257-
1 p.
 article
40 Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review Horowitz, Netanel A
 2013
 14 7 p. e275-e282
nvt p.
 article
41 Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Kuehn, Thorsten
 2013
 14 7 p. 609-618
10 p.
 article
42 Sentinel node biopsy and neoadjuvant chemotherapy Cody III, Hiram S
 2013
 14 7 p. 567-568
2 p.
 article
43 Speculation overinflates long-term efficacy of vaccine for anal dysplasia Talboy, Glenn E
 2013
 14 7 p. e249-e250
nvt p.
 article
44 Surrogate endpoints: can size of effect mitigate perplexity? Perrone, Francesco
 2013
 14 7 p. 568-569
2 p.
 article
45 Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data Mauguen, Audrey
 2013
 14 7 p. 619-626
8 p.
 article
46 Targeted therapy and chemoradiotherapy in oesophageal cancer Burmeister, Bryan H
 2013
 14 7 p. 569-570
2 p.
 article
47 The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached? Abou-Alfa, Ghassan K
 2013
 14 7 p. e283-e288
nvt p.
 article
48 The Fault in Our Stars O'Donoghue, Odhran
 2013
 14 7 p. 581-582
2 p.
 article
49 Treating basal-cell carcinoma in a real life setting Dummer, Reinhard
 2013
 14 7 p. 572-573
2 p.
 article
50 Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Senan, Suresh
 2013
 14 7 p. e270-e274
nvt p.
 article
51 Two or three doses of human papillomavirus vaccine? Baker, Holly
 2013
 14 7 p. e260-
1 p.
 article
52 UK Government panders to tobacco industry and lacks social conscience The Lancet Oncology,
 2013
 14 7 p. 563-
1 p.
 article
53 Zooming in on the schedule of bone-modifying drugs Martin, Miguel
 2013
 14 7 p. 575-576
2 p.
 article
                             53 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands